MAD2L1 and neoplasm: Given the existing in vivo evidence indicating that elevated glucose levels are associated with the upregulation of MAD2L1 expression in tumor tissues,[12] it is crucial to determine whether this alteration occurs within the tumor cells or in the surrounding microenvironment.